Related Experiment Video
Updated: Dec 27, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
Jose J G Marin1, Rocio I R Macias1, Candela Cives-Losada1
1HEVEFARM Group, Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health. University of Salamanca, IBSAL, 37007-Salamanca, Spain.
Abstract:
The dismal prognosis of patients with advanced cholangiocarcinoma (CCA) is due, in part, to the extreme resistance of this type of liver cancer to available chemotherapeutic agents. Among the complex mechanisms accounting for CCA chemoresistance are those involving the impairment of drug uptake, which mainly occurs through transporters of the superfamily of solute carrier (SLC) proteins, and the active export of drugs from cancer cells, mainly through members of families B, C and G of ATP-binding cassette (ABC) proteins. Both mechanisms result in decreased amounts of active drugs able to reach their intracellular targets. Therefore, the "cancer transportome", defined as the set of transporters expressed at a given moment in the tumor, is an essential element for defining the multidrug resistance (MDR) phenotype of cancer cells. For this reason, during the last two decades, plasma membrane transporters have been envisaged as targets for the development of strategies aimed at sensitizing cancer cells to chemotherapy, either by increasing the uptake or reducing the export of antitumor agents by modulating the expression/function of SLC and ABC proteins, respectively. Moreover, since some elements of the transportome are differentially expressed in CCA, their usefulness as biomarkers with diagnostic and prognostic purposes in CCA patients has been evaluated.
Insights
Cholangiocarcinoma (CCA) liver cancer is resistant to chemotherapy due to impaired drug transport. Targeting solute carrier (SLC) and ATP-binding cassette (ABC) transporters offers new strategies to overcome multidrug resistance (MDR) in CCA.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Advanced cholangiocarcinoma (CCA) exhibits extreme resistance to chemotherapy, contributing to poor patient prognosis.
- Chemoresistance mechanisms in CCA involve impaired drug uptake via solute carrier (SLC) proteins and active drug export by ATP-binding cassette (ABC) proteins.
- These transport processes reduce intracellular concentrations of chemotherapeutic agents, limiting their efficacy.
Purpose of the Study:
- To explore the role of the cancer transportome in CCA chemoresistance.
- To evaluate plasma membrane transporters as potential therapeutic targets for sensitizing CCA to chemotherapy.
- To assess the utility of differentially expressed transporters as diagnostic and prognostic biomarkers in CCA.
Main Methods:
- Analysis of the cancer transportome, focusing on solute carrier (SLC) and ATP-binding cassette (ABC) proteins.
- Investigation of mechanisms regulating drug uptake and export in CCA cells.
- Evaluation of transporter expression patterns for potential biomarker applications.
Main Results:
- The cancer transportome, comprising SLC and ABC proteins, is crucial in defining the multidrug resistance (MDR) phenotype of CCA cells.
- Modulating the expression or function of SLC and ABC transporters presents a strategy to enhance chemotherapy sensitivity.
- Certain transporters are differentially expressed in CCA, suggesting their potential as diagnostic or prognostic markers.
Conclusions:
- Targeting the cancer transportome, specifically SLC and ABC transporters, is a promising approach to overcome chemotherapy resistance in cholangiocarcinoma.
- Understanding transporter roles can lead to novel therapeutic strategies and improved diagnostic/prognostic tools for CCA patients.
More Related Videos
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
08:42Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Related Concept Videos
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Hepatic Drug Clearance: Role of Transporters
Membrane Proteins
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.